APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C5 Complement Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global C5 Complement Inhibitor Industry Growth and Trends Forecast to 2032

Report ID 173973550122 December 202573 pages

Choose your research edition.

Industry ResearchC5 Complement Inhibitor Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal C5 Complement Inhibitor Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal C5 Complement Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C5 Complement Inhibitor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal C5 Complement Inhibitor Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global C5 Complement Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for C5 Complement Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for C5 Complement Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C5 Complement Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C5 Complement Inhibitor include Alexion. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global C5 Complement Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The C5 Complement Inhibitor market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C5 Complement Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C5 Complement Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global C5 Complement Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

C5 Complement Inhibitor Market by Company

Alexion

C5 Complement Inhibitor Segment by Type

Eculizumab

Raflizumab

C5 Complement Inhibitor Segment by Application

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Atypical Hemolytic Uremic Syndrome (aHUS)

Other

C5 Complement Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C5 Complement Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C5 Complement Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C5 Complement Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of C5 Complement Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of C5 Complement Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Eculizumab Table 2. Major Company of Raflizumab Table 3. Global C5 Complement Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 5. Global C5 Complement Inhibitor Sales Market Share in Volume by Type (2021-2026) Table 6. Global C5 Complement Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 7. Global C5 Complement Inhibitor Sales Market Share in Value by Type (2021-2026) Table 8. Global C5 Complement Inhibitor Price by Type (2021-2026) & (US$/unit) Table 9. Global C5 Complement Inhibitor Sales by Type (2027-2032) & (k units) Table 10. Global C5 Complement Inhibitor Sales Market Share in Volume by Type (2027-2032) Table 11. Global C5 Complement Inhibitor Sales by Type (2027-2032) & (US$ Million) Table 12. Global C5 Complement Inhibitor Sales Market Share in Value by Type (2027-2032) Table 13. Global C5 Complement Inhibitor Price by Type (2027-2032) & (US$/unit) Table 14. North America C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 15. North America C5 Complement Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 16. Europe C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 17. Europe C5 Complement Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific C5 Complement Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 21. Latin America C5 Complement Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa C5 Complement Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 24. C5 Complement Inhibitor Industry Trends Table 25. C5 Complement Inhibitor Industry Drivers Table 26. C5 Complement Inhibitor Industry Opportunities and Challenges Table 27. C5 Complement Inhibitor Industry Restraints Table 28. Global C5 Complement Inhibitor Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global C5 Complement Inhibitor Revenue Market Share by Company (2021-2026) Table 30. Global C5 Complement Inhibitor Sales by Company (2021-2026) & (k units) Table 31. Global C5 Complement Inhibitor Sales Share by Company (2021-2026) Table 32. Global C5 Complement Inhibitor Market Price by Company (2021-2026) & (US$/unit) Table 33. Global C5 Complement Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global C5 Complement Inhibitor Major Company Production Sites and Headquarters Table 35. Global C5 Complement Inhibitor Company, Product Type & Application Table 36. Global C5 Complement Inhibitor Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global C5 Complement Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global C5 Complement Inhibitor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global C5 Complement Inhibitor Sales by Region (2021-2026) & (k units) Table 41. Global C5 Complement Inhibitor Sales Market Share in Volume by Region (2021-2026) Table 42. Global C5 Complement Inhibitor Sales by Region (2021-2026) & (US$ Million) Table 43. Global C5 Complement Inhibitor Sales Market Share in Value by Region (2021-2026) Table 44. Global C5 Complement Inhibitor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global C5 Complement Inhibitor Sales by Region (2027-2032) & (k units) Table 46. Global C5 Complement Inhibitor Sales Market Share in Volume by Region (2027-2032) Table 47. Global C5 Complement Inhibitor Sales by Region (2027-2032) & (US$ Million) Table 48. Global C5 Complement Inhibitor Sales Market Share in Value by Region (2027-2032) Table 49. Global C5 Complement Inhibitor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global C5 Complement Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 52. Global C5 Complement Inhibitor Sales Market Share in Volume by Application (2021-2026) Table 53. Global C5 Complement Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 54. Global C5 Complement Inhibitor Sales Market Share in Value by Application (2021-2026) Table 55. Global C5 Complement Inhibitor Price by Application (2021-2026) & (US$/unit) Table 56. Global C5 Complement Inhibitor Sales by Application (2027-2032) & (k units) Table 57. Global C5 Complement Inhibitor Sales Market Share in Volume by Application (2027-2032) Table 58. Global C5 Complement Inhibitor Sales by Application (2027-2032) & (US$ Million) Table 59. Global C5 Complement Inhibitor Sales Market Share in Value by Application (2027-2032) Table 60. Global C5 Complement Inhibitor Price by Application (2027-2032) & (US$/unit) Table 61. North America C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 62. North America C5 Complement Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 63. Europe C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 64. Europe C5 Complement Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific C5 Complement Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 68. Latin America C5 Complement Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa C5 Complement Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 71. Alexion Company Information Table 72. Alexion Business Overview Table 73. Alexion C5 Complement Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Alexion C5 Complement Inhibitor Product Portfolio Table 75. Alexion Recent Development Table 76. North America C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 77. North America C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 78. North America C5 Complement Inhibitor Sales Market Share by Country (2021-2026) Table 79. North America C5 Complement Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 80. North America C5 Complement Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 81. North America C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America C5 Complement Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 83. North America C5 Complement Inhibitor Market Share by Country (2021-2026) Table 84. North America C5 Complement Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America C5 Complement Inhibitor Market Share Forecast by Country (2027-2032) Table 86. Europe C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. Europe C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 88. Europe C5 Complement Inhibitor Sales Market Share by Country (2021-2026) Table 89. Europe C5 Complement Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 90. Europe C5 Complement Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 91. Europe C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe C5 Complement Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe C5 Complement Inhibitor Market Share by Country (2021-2026) Table 94. Europe C5 Complement Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe C5 Complement Inhibitor Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 98. Asia-Pacific C5 Complement Inhibitor Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific C5 Complement Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 100. Asia-Pacific C5 Complement Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific C5 Complement Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific C5 Complement Inhibitor Market Share by Country (2021-2026) Table 104. Asia-Pacific C5 Complement Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific C5 Complement Inhibitor Market Share Forecast by Country (2027-2032) Table 106. Latin America C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Latin America C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 108. Latin America C5 Complement Inhibitor Sales Market Share by Country (2021-2026) Table 109. Latin America C5 Complement Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 110. Latin America C5 Complement Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America C5 Complement Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America C5 Complement Inhibitor Market Share by Country (2021-2026) Table 114. Latin America C5 Complement Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America C5 Complement Inhibitor Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 118. Middle East and Africa C5 Complement Inhibitor Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa C5 Complement Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 120. Middle East and Africa C5 Complement Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa C5 Complement Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa C5 Complement Inhibitor Market Share by Country (2021-2026) Table 124. Middle East and Africa C5 Complement Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa C5 Complement Inhibitor Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. C5 Complement Inhibitor Distributors List Table 129. C5 Complement Inhibitor Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. C5 Complement Inhibitor Image Figure 2. Global C5 Complement Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C5 Complement Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global C5 Complement Inhibitor Sales (2021-2032) & (k units) Figure 5. Eculizumab Image Figure 6. Global Eculizumab Sales YoY Growth (2021-2032) & (k units) Figure 7. Raflizumab Image Figure 8. Global Raflizumab Sales YoY Growth (2021-2032) & (k units) Figure 9. Global C5 Complement Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global C5 Complement Inhibitor Market Share by Type 2025 VS 2032 Figure 11. North America C5 Complement Inhibitor Sales Market Share in Volume by Type in 2025 Figure 12. North America C5 Complement Inhibitor Sales Market Share in Value by Type in 2025 Figure 13. Europe C5 Complement Inhibitor Sales Market Share in Volume by Type in 2025 Figure 14. Europe C5 Complement Inhibitor Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific C5 Complement Inhibitor Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific C5 Complement Inhibitor Sales Market Share in Value by Type in 2025 Figure 17. Latin America C5 Complement Inhibitor Sales Market Share in Volume by Type in 2025 Figure 18. Latin America C5 Complement Inhibitor Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa C5 Complement Inhibitor Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa C5 Complement Inhibitor Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 C5 Complement Inhibitor Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Paroxysmal Nocturnal Hemoglobinuria (PNH) Image Figure 24. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Sales YoY Growth (2021-2032) & (k units) Figure 25. Atypical Hemolytic Uremic Syndrome (aHUS) Image Figure 26. Global Atypical Hemolytic Uremic Syndrome (aHUS) Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global C5 Complement Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global C5 Complement Inhibitor Market Share by Application 2025 VS 2032 Figure 31. North America C5 Complement Inhibitor Sales Market Share in Volume by Application in 2025 Figure 32. North America C5 Complement Inhibitor Sales Market Share in Value by Application in 2025 Figure 33. Europe C5 Complement Inhibitor Sales Market Share in Volume by Application in 2025 Figure 34. Europe C5 Complement Inhibitor Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific C5 Complement Inhibitor Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific C5 Complement Inhibitor Sales Market Share in Value by Application in 2025 Figure 37. Latin America C5 Complement Inhibitor Sales Market Share in Volume by Application in 2025 Figure 38. Latin America C5 Complement Inhibitor Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa C5 Complement Inhibitor Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa C5 Complement Inhibitor Sales Market Share in Value by Application in 2025 Figure 41. North America C5 Complement Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America C5 Complement Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America C5 Complement Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America C5 Complement Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe C5 Complement Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe C5 Complement Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe C5 Complement Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe C5 Complement Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific C5 Complement Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific C5 Complement Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific C5 Complement Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific C5 Complement Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America C5 Complement Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America C5 Complement Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America C5 Complement Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America C5 Complement Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa C5 Complement Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa C5 Complement Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa C5 Complement Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa C5 Complement Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. C5 Complement Inhibitor Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. C5 Complement Inhibitor Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Eculizumab
  • Raflizumab
Applications
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Other
Companies covered
  • Alexion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global C5 Complement Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global C5 Complement Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 C5 Complement Inhibitor Market by Type
  6. 1.3.1 Eculizumab
  7. 1.3.2 Raflizumab
  8. 1.4 Global C5 Complement Inhibitor Market Size by Type
  9. 1.4.1 Global C5 Complement Inhibitor Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global C5 Complement Inhibitor Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global C5 Complement Inhibitor Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America C5 Complement Inhibitor Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe C5 Complement Inhibitor Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific C5 Complement Inhibitor Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America C5 Complement Inhibitor Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa C5 Complement Inhibitor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 C5 Complement Inhibitor Industry Trends
  2. 2.2 C5 Complement Inhibitor Industry Drivers
  3. 2.3 C5 Complement Inhibitor Industry Opportunities and Challenges
  4. 2.4 C5 Complement Inhibitor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by C5 Complement Inhibitor Revenue (2021-2026)
  2. 3.2 Global Top Players by C5 Complement Inhibitor Sales (2021-2026)
  3. 3.3 Global Top Players by C5 Complement Inhibitor Price (2021-2026)
  4. 3.4 Global C5 Complement Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global C5 Complement Inhibitor Major Company Production Sites & Headquarters
  6. 3.6 Global C5 Complement Inhibitor Company, Product Type & Application
  7. 3.7 Global C5 Complement Inhibitor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global C5 Complement Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 C5 Complement Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 C5 Complement Inhibitor Tier 1, Tier 2, and Tier 3
4 C5 Complement Inhibitor Regional Status and Outlook
  1. 4.1 Global C5 Complement Inhibitor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global C5 Complement Inhibitor Historic Market Size by Region
  3. 4.2.1 Global C5 Complement Inhibitor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global C5 Complement Inhibitor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global C5 Complement Inhibitor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global C5 Complement Inhibitor Forecasted Market Size by Region
  7. 4.3.1 Global C5 Complement Inhibitor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global C5 Complement Inhibitor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global C5 Complement Inhibitor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 C5 Complement Inhibitor by Application
  1. 5.1 C5 Complement Inhibitor Market by Application
  2. 5.1.1 Paroxysmal Nocturnal Hemoglobinuria (PNH)
  3. 5.1.2 Atypical Hemolytic Uremic Syndrome (aHUS)
  4. 5.1.3 Other
  5. 5.2 Global C5 Complement Inhibitor Market Size by Application
  6. 5.2.1 Global C5 Complement Inhibitor Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global C5 Complement Inhibitor Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global C5 Complement Inhibitor Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America C5 Complement Inhibitor Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe C5 Complement Inhibitor Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific C5 Complement Inhibitor Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America C5 Complement Inhibitor Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa C5 Complement Inhibitor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alexion
  2. 6.1.1 Alexion Company Information
  3. 6.1.2 Alexion Business Overview
  4. 6.1.3 Alexion C5 Complement Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alexion C5 Complement Inhibitor Product Portfolio
  6. 6.1.5 Alexion Recent Developments
7 North America by Country
  1. 7.1 North America C5 Complement Inhibitor Sales by Country
  2. 7.1.1 North America C5 Complement Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America C5 Complement Inhibitor Sales by Country (2021-2026)
  4. 7.1.3 North America C5 Complement Inhibitor Sales Forecast by Country (2027-2032)
  5. 7.2 North America C5 Complement Inhibitor Market Size by Country
  6. 7.2.1 North America C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America C5 Complement Inhibitor Market Size by Country (2021-2026)
  8. 7.2.3 North America C5 Complement Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe C5 Complement Inhibitor Sales by Country
  2. 8.1.1 Europe C5 Complement Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe C5 Complement Inhibitor Sales by Country (2021-2026)
  4. 8.1.3 Europe C5 Complement Inhibitor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe C5 Complement Inhibitor Market Size by Country
  6. 8.2.1 Europe C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe C5 Complement Inhibitor Market Size by Country (2021-2026)
  8. 8.2.3 Europe C5 Complement Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific C5 Complement Inhibitor Sales by Country
  2. 9.1.1 Asia-Pacific C5 Complement Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific C5 Complement Inhibitor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific C5 Complement Inhibitor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific C5 Complement Inhibitor Market Size by Country
  6. 9.2.1 Asia-Pacific C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific C5 Complement Inhibitor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific C5 Complement Inhibitor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America C5 Complement Inhibitor Sales by Country
  2. 10.1.1 South America C5 Complement Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America C5 Complement Inhibitor Sales by Country (2021-2026)
  4. 10.1.3 South America C5 Complement Inhibitor Sales Forecast by Country (2027-2032)
  5. 10.2 South America C5 Complement Inhibitor Market Size by Country
  6. 10.2.1 South America C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America C5 Complement Inhibitor Market Size by Country (2021-2026)
  8. 10.2.3 South America C5 Complement Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa C5 Complement Inhibitor Sales by Country
  2. 11.1.1 Middle East and Africa C5 Complement Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa C5 Complement Inhibitor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa C5 Complement Inhibitor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa C5 Complement Inhibitor Market Size by Country
  6. 11.2.1 Middle East and Africa C5 Complement Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa C5 Complement Inhibitor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa C5 Complement Inhibitor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 C5 Complement Inhibitor Value Chain Analysis
  2. 12.1.1 C5 Complement Inhibitor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 C5 Complement Inhibitor Production Mode & Process
  7. 12.2 C5 Complement Inhibitor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 C5 Complement Inhibitor Distributors
  10. 12.2.3 C5 Complement Inhibitor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst